June 18, 2009 Dear Myriad Genetics, Inc. Stockholder: I am pleased to inform you that the Board of Directors of Myriad Genetics, Inc. (“Myriad Genetics”) has approved the distribution of all of the shares of common s

First Page		Document Content
Date: 2012-10-18 13:12:14 Myriad Genetics Bevirimat Melanoma Glioblastoma multiforme Hsp90 inhibitors Brain tumor Medicine Cancer research		June 18, 2009 Dear Myriad Genetics, Inc. Stockholder: I am pleased to inform you that the Board of Directors of Myriad Genetics, Inc. (“Myriad Genetics”) has approved the distribution of all of the shares of common s Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 450,76 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.